Additionally, our studies suggest that the ALDHbright population validates the CSC phenotype based on the increased expression of brain cancer stem cells genes such as ALDH1A1, ITGA6, THY1, PROM1, and SOX2, as reported previously. This evidence concerns the gene ITGA6 and brain cancer.